Medtech | Ophthalmology Innovation Source

Alcon – Google Innovation: Visions of Ophthalmology in 2020

Participants: William J. Link, PhD Prior to Versant, Bill was a general partner at Brentwood Venture Capital. He founded, and served as chairman and CEO of Chiron Vision. Chiron Vision was sold to Bausch and Lomb in 1997. View Full Profile Laurent Attias Laurent Attias is currently Senior Vice President, Head of Strategy, BD&L and…

Thinking About Market Cycles & Growth in the Ophthalmology Sector

A panel of Wall Street analysts offer their insights on the future performance of the public markets, including ophthalmology stocks at OIS@AAO in Las Vegas. Participants: Emmett T. Cunningham Jr., MD, PhD, MPH Dr. Cunningham, currently a Partner, joined Clarus in 2006 with more than 20 years of experience in the biomedical and biopharmaceutical sectors.…

Implandata

Implandata Ophthalmic Products GmbH (IOP GmbH), located in Hanover/Germany, is destined to transform management of glaucoma patients via a unique solution for early detection of elevated intraocular pressure (IOP), for reliable IOP patient self-measurement, for vastly improved disease monitoring and glaucoma therapy and for more efficient remote patient care. www.implandata.com Participant: Max G. Ostermeier, MBA…

International Biomedical Devices

IBMD is an early-stage medical device company focused in ophthalmology innovations. The company is leading the emerging, non-laser based, precision capsulotomy category through the development of a unique capsulotomy technology. ApertureCTC™ represents a considerable improvement to traditional surgical techniques by ensuring safe and precise capsulotomies and predictable outcomes for patients. www.aperturectc.com

MEDICEM

MEDICEM is a group of biomedical companies focusing on research, development and commercialization of medical devices. Our WIOL–CF Bioanalogic Polyfocal IOL, represents new step in evolution of IOLs for the patients with cataract and presbyopia. WIOL-CF offers vision to all distances, including restored reading capability, in all light conditions. www.medicem.com

Mynosys Cellular Devices

Zepto is an innovative disposable device, used in cataract surgery that uses precision pulse technology. The company notes the device is accurate and creates a reproducible capsulotomy that is quick, safe, and affordable. Zepto consists of a silicon suction cup, a nitinol capsulotomy cutting element and an incision finder/push-rod system. The system works by stretching…

Biggest OIS Ever Set to Deliver News & Insights

The maturation and advance of the ophthalmology sector will be fully evident tomorrow as we host the largest Ophthalmology Innovation Summit in its seven-year history. More than 900 clinicians, investors, and executives will descend upon the Planet Hollywood Hotel in Las Vegas to grab a glimpse of novel new treatments for ophthalmology disorders. Three dozen…

Understanding Market Cycles: When Could Biotech UnBoom?

[creativ_pullleft colour=”light-gray” colour_custom=”” text=”Episode 061″] David Nierengarten, Managing Director, Wedbush Securities, explains how public market cycles could hit biotech and ophthalmology companies. Podcast Guest David Nierengarten, PhD David Nierengarten is a senior biotechnology equity analyst with Wedbush Securities, mainly covering development-stage therapeutic companies. He began his career on the financial side of biotechnology at a…

Gene Therapies Move One Step Closer to Reality

Positive top-line results from a pivotal Phase III study may result in the first gene therapy to win U.S. regulatory approval, and sent shares of the developer skyrocketing. Earlier this week, Spark Therapeutics (Philadelphia) announced its lead candidate, SPK-RPE65, was able to improve functional vision in patients with a rare form of a genetic disorder…

Implandata’s Hands-On Approach To Tracking IOP

[creativ_pullleft colour=”light-gray” colour_custom=”” text=”Episode 059″] Implandata Ophthalmic Products GmbH is putting the task of tracking intraocular pressure into the hands of patients. Company Co-Founder and General Manager Max G. Ostermeier shares the story of EyeMate, an implantable micro sensor capable of measuring absolute intraocular pressure continuously or on demand. Podcast Guest Max G. Ostermeier, MBA…

OcuSciences Hopes To Give Early Warning On Ocular Disease

[creativ_pullleft colour=”light-gray” colour_custom=”” text=”Episode 057″] Kurt Riegger, President and COO of OcuSciences, tells a start-up’s tale. OcuSciences’ OcuMet Beacon is being developed to give optometrists and ophthalmologies the ability to see the onset of disease earlier than ever. Transcript: Tom Salemi: Hi, everyone. This is Tom Salemi, content director of Healthegy and your host of…

Revenue Report Card for Recent IPO Class

As a rule, medical device companies have to demonstrate some level of commercial viability if they’re going to go public. A few are able to stage an IPO without meaningful revenue. However, most other device companies that have gone public lately have had to prove that customers are buying what they’re selling. And now that…